Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

ClinicalTrials.gov ID: NCT03361501

Public ClinicalTrials.gov record NCT03361501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Multi-national, Placebo-controlled, Randomized, Double-blind 26 Week Study to Assess the Safety and Efficacy of CaPre® in Patients With Severe Hypertriglyceridemia

Study identification

NCT ID
NCT03361501
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Grace Therapeutics Inc.
Industry
Enrollment
278 participants

Conditions and interventions

Interventions

  • CaPre Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2018
Primary completion
Sep 23, 2019
Completion
Jan 8, 2020
Last update posted
Aug 11, 2020

2018 – 2020

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
47
Facility City State ZIP Site status
Research site Birmingham Alabama 35216
Research site Childersburg Alabama 35044
Research site Encino California 91436
Research site Long Beach California 90806
Research site San Diego California 92111
Research site Thousand Oaks California 91360
Research site Torrance California 90503
Research site Monument Colorado 80132
Research site Clearwater Florida 33756
Research site Coral Gables Florida 33134
Research site DeLand Florida 32720
Research site Fort Lauderdale Florida 33308
Research site Jacksonville Florida 32205
Research site Jacksonville Florida 32277
Research site Miami Florida 33133
Research site Miami Florida 33134
Research site Miami Florida 33144
Research site Miami Lakes Florida 33016
Research site Dunwoody Georgia 30338
Research site Peachtree Corners Georgia 30071
Research site Savannah Georgia 31406
Research site Boise Idaho 83712
Research site Wauconda Illinois 60084
Research site Iowa City Iowa 52242
Research site Overland Park Kansas 66210
Research site Biddeford Maine 04005
Research site Baltimore Maryland 21229
Research site Hyattsville Maryland 20782
Research site Flint Michigan 48503
Research site Tupelo Mississippi 38801
Research site Norfolk Nebraska 68701
Research site Las Vegas Nevada 89120
Research site Las Vegas Nevada 89169
Research site Albany New York 12206
Research site Laurelton New York 11413
Research site New Windsor New York 12553
Research site New York New York 10036
Research site The Bronx New York 10468
Research site Morganton North Carolina 28655
Research site Marion Ohio 43302
Research site Oklahoma City Oklahoma 73112
Research site Lansdale Pennsylvania 19446
Research site Gaffney South Carolina 29340
Research site Summerville South Carolina 29485
Research site Union South Carolina 29379
Research site Georgetown Texas 78626
Research site Houston Texas 77043
Research site Houston Texas 77074
Research site Houston Texas 77079
Research site Kerrville Texas 78028
Research site Clinton Utah 84015
Research site Ogden Utah 84405
Research site Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03361501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2020 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03361501 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →